$25.9 Million is the total value of UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO's 11 reported holdings in Q2 2020. The portfolio turnover from Q1 2020 to Q2 2020 was 44.4% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| VT | VANGUARD TOTAL WORLD STOCK ETFetfs | $13,581,000 | +19.1% | 181,558 | 0.0% | 52.51% | +233.8% | |
| TXN | TEXAS INSTRUMENTS INC | $4,063,000 | +27.0% | 32,000 | 0.0% | 15.71% | +256.1% | |
| SOLY | SOLITON INC | $3,307,000 | -4.0% | 425,000 | 0.0% | 12.79% | +169.2% | |
| AGLE | Sell | AEGLEA BIOTHERAPEUTICS INC | $2,587,000 | +72.0% | 279,678 | -13.3% | 10.00% | +382.1% |
| AMGN | New | AMGEN INC | $853,000 | – | 3,615 | +100.0% | 3.30% | – |
| SYK | New | STRYKER CORP | $685,000 | – | 3,800 | +100.0% | 2.65% | – |
| APEN | Buy | APOLLO ENDOSURGERY INC | $456,000 | +1420.0% | 279,037 | +1688.6% | 1.76% | +4200.0% |
| PLXP | PLX PHARMA INC | $203,000 | +44.0% | 62,673 | 0.0% | 0.78% | +302.6% | |
| LXRX | LEXICON PHARMACEUTICALS INC | $71,000 | +1.4% | 35,714 | 0.0% | 0.28% | +183.5% | |
| SQ | New | SQUARE INC | $52,000 | – | 500 | +100.0% | 0.20% | – |
| POR | PORTLAND GENERAL ELECTRIC CO | $5,000 | -16.7% | 118 | 0.0% | 0.02% | +137.5% | |
| SPY | Exit | SPDR TRUST SERIES 1etfs | $0 | – | -204,446 | -100.0% | -72.69% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-08-04
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| TEXAS INSTRUMENTS INC | 41 | Q3 2023 | 31.2% |
| PORTLAND GENERAL ELECTRIC CO | 38 | Q3 2023 | 0.0% |
| LEXICON PHARMACEUTICALS INC | 33 | Q3 2023 | 1.7% |
| AEGLEA BIOTHERAPEUTICS INC | 27 | Q2 2023 | 11.0% |
| APOLLO ENDOSURGERY INC | 24 | Q1 2023 | 5.6% |
| PLX PHARMA INC | 23 | Q1 2023 | 1.7% |
| VANGUARD MSCI EMERGING MKTS | 22 | Q2 2019 | 10.3% |
| VANGUARD ENERGY ETF | 22 | Q2 2019 | 8.7% |
| VANGUARD S&P 500 ETF | 21 | Q3 2023 | 11.8% |
| VANGUARD MSCI EAFE ETF | 20 | Q2 2019 | 13.1% |
View UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Taysha Gene Therapies, Inc. | September 24, 2021 | 1,156,255 | 3.0% |
| ZIOPHARM ONCOLOGY INC | February 12, 2016 | 9 | 0.0% |
View UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2024-05-01 |
| 3 | 2024-04-30 |
| 13F-HR | 2024-04-30 |
| 144 | 2024-04-29 |
| SC 13G | 2024-03-05 |
| 13F-HR | 2024-02-28 |
| SC 13G | 2024-02-14 |
| 13F-HR | 2023-11-09 |
| 13F-HR | 2023-08-04 |
| 3 | 2023-06-02 |
View UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.